In this study, we combined functional analysis of short-term melanoma cell models with high dimensional flow cytometric profiling of matched tumor samples from melanoma patients progressing on PD1 inhibitor monotherapy or in combination with the CTLA4 inhibitor, ipilimumab. Here, PDCD1 is linked to melanoma.